Turkey has signed a cope with BioNTech, the German agency behind the mRNA-based coronavirus vaccine, for as much as 30 million doses of the jab, Well being Minister Fahrettin Koca stated in a tweet late Friday, Pattern experiences citing Every day Sabah.
The present inventory stands at 550,000 doses and Turkey will get 4.5 million doses by the tip of March, Koca added.
“In keeping with our deal, as much as 30 million doses might be supplied beneath the identical situations,” he stated.
Koca additionally revealed the rationale for the delay within the deal between Turkey and the corporate.
“The rationale for the delay was the truth that the producer didn’t settle for any accountability with reference to potential issues that might come up from the manufacturing,” he stated, including that the disagreement was later solved. “Residents who wish to get a dose might be requested for an knowledgeable consent,” he stated.
Koca additionally thanked Turkish-German Professor Uğur Şahin, a co-founder of the BioNTech.
“Professor Şahin strived onerous to take away obstacles hindering the signing of the deal. The truth that he granted that privilege to Turkey is not going to be forgotten. I wish to thank him on behalf of our nation as soon as once more,” the minister concluded.
BioNTech’s vaccine, developed along with U.S. pharmaceutical firm Pfizer, is allowed to be used in additional than 45 international locations, together with Britain and the USA, in addition to within the European Union.